Pressure Ulcer: Clinical Trials

27 trials for Pressure Ulcer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 4 terminated, 3 unknown, 2 not yet recruiting. 27 Phase 2, 11 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 227Completed 13, Terminated 4, Unknown 3, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1, Recruiting 1, Suspended 1
Phase 111Completed 5, Unknown 3, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Phase 31Completed 1

Follow Pressure Ulcer: new trials by email Literature Review of Pressure Ulcer trials Research Report on Pressure Ulcer

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of GM-XANTHO in Pressure Ulcer Patients
GM-XANTHO - Pressure Ulcer, Diabetes Mellitus
Phase 2Not yet recruitingXantho Biotechnology Co., LTD582026-09-012025-09-03
Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers
PRFM - Lower Extremity, Chronic Ulcers
Phase 1 / Phase 2Not yet recruitingTiger Biosciences, LLC.302026-09-012026-10-07
A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.
STIMULAN VG, Standard of Care - Pressure Ulcer, Stage IV, Osteomyelitis
Phase 2RecruitingBiocomposites Ltd602025-06-152026-05-06
Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells for Stage 3 and 4 Stress Injury
Platelet-rich plasma (PRP) combined with human umbilical cord mesenchymal stem cells (huMSCs), Control group - Pressure Injuries - Stage 3, Pressure Injuries - Stage 4
Phase 1 / Phase 2UnknownLiaocheng People's Hospital402024-02-292024-03-12
Skin Change Actions by Nursing
SEM Scanner - Pressure Injury
Phase 2CompletedUniversity of California, Los Angeles47332022-12-042026-10-06
Phage Therapy for the Prevention and Treatment of Pressure Ulcers.
Bacteriophage-loaded Microcapsule Spray, Placebo, Standard of Care - Pressure Ulcer
Phase 1 / Phase 2UnknownPrecisio Biotix Therapeutics, Inc.692022-01-012021-12-21
Wound Healing Endpoint and Recurrence
Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound
Phase 1 / Phase 2Active not recruitingSashwati Roy1002019-01-082025-09-26
Skin Blood Flow Response to Insulin Iontophoresis in Pressure Ulcers of SCI
Pioglitazone, Placebo - Spinal Cord Injury, Pressure Ulcers
Phase 2WithdrawnJames J. Peters Veterans Affairs Medical Center2017-02-012018-08-08
Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia
Leia - Leg Ulcer, Diabetic Foot Ulcer
Phase 2TerminatedMolnlycke Health Care AB62013-09-012015-12-23
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Adipose derived stem cells - Diabetic Foot, Venous Ulcer
Phase 2CompletedTower Outpatient Surgical Center252013-09-012019-09-11
Insulin Complexation With Hydroxypropyl-beta-cyclodextrin: Use of the Complex in Gel for Healing of Pressure Ulcers
Gel with HPβCD-I complex, Gel with insulin, Control gel - Pressure Ulcer, Wound
Phase 1 / Phase 2CompletedState University of Maringá152013-03-012016-01-14
Reference Nurse Program for Pressure Ulcers in Primary Care
Tele-assistance, Active comparator - Pressure Ulcers
Phase 2CompletedBasque Health Service582012-10-012015-04-16
Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Pressure Sore
Nitric Oxide, placebo - Pressure Ulcer
Phase 1 / Phase 2UnknownChina Medical University Hospital402012-07-012012-07-11
Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
HP011-101 (Xenaderm Ointment), Standard Care - Pressure Ulcers, Spinal Cord Injury
Phase 2TerminatedHealthpoint192011-09-012014-02-10
Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers
OPAL A, Placebo - Venous Ulcer, Pressure Ulcer
Phase 2SuspendedPhoenix Eagle Company302010-01-012014-10-30
Interdisciplinary Mobility Approach To Reduction Of Facility-Acquired Pressure Ulcers
Musical prompt, Delayed musical prompt, No musical prompt - Pressure Ulcers
Phase 2 / Phase 3CompletedUniversity of Cincinnati20002009-09-012011-10-19
Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers
Procellera™ Wound Dressing with V.A.C.® Therapy, V.A.C.® Therapy - Wound Healing
Phase 2CompletedVomaris Innovations302009-08-012012-02-22
Reduction of Bacteria in MRSA Positive Ulcers
Nitric Oxide - Leg Ulcer, Pressure Ulcer
Phase 1 / Phase 2TerminatedNitric BioTherapeutics, Inc202009-01-012012-01-19
Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment
Infusion of autologous bone marrow stem cells after wound debridement. - Type IV Pressure Ulcers, Chronic Wounds
Phase 1 / Phase 2CompletedHospital Universitario Central de Asturias302007-11-012015-08-25
Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)
ALO-01, MSIR, Placebo - Healthy
Phase 1 / Phase 2CompletedPfizer322007-03-012013-09-16

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Diabetic Foot (5)  ·  Spinal Cord Injuries (4)  ·  Wounds and Injuries (4)  ·  Varicose Ulcer (3)  ·  Diabetes Mellitus (2)  ·  Leg Ulcer (2)  ·  Ulcer (2)  ·  Agnosia (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Burns (1)  ·  Insulin Resistance (1)  ·  Osteomyelitis (1)  ·  Pain (1)  ·  Paraplegia (1)

Broader conditions

Skin Diseases (27)  ·  Skin Ulcer (27)  ·  Skin and Connective Tissue Diseases (27)  ·  Cardiovascular Diseases (7)  ·  Vascular Diseases (7)  ·  Endocrine System Diseases (6)  ·  Leg Ulcer (6)  ·  Nervous System Diseases (6)  ·  Diabetes Complications (5)  ·  Diabetic Angiopathies (5)  ·  Diabetic Neuropathies (5)  ·  Foot Ulcer (5)  ·  Central Nervous System Diseases (4)  ·  Diabetes Mellitus (4)  ·  Spinal Cord Diseases (4)

Interventions

Standard of Care (4)  ·  Nitric Oxide (2)  ·  Albumins (1)  ·  Analgesia (1)  ·  Control Groups (1)  ·  Gels (1)  ·  Insulin (1)  ·  Negative-Pressure Wound Therapy (1)  ·  Petroleum (1)  ·  Pioglitazone (1)  ·  Sodium Chloride (1)  ·  morphine, naltrexone combination (1)  ·  thymosin beta(4) (1)

Sponsors

Healthpoint (2)  ·  US Department of Veterans Affairs (2)  ·  Basque Health Service (1)  ·  Bayside Health (1)  ·  Biocomposites Ltd (1)  ·  China Medical University Hospital (1)  ·  Hospital Universitario Central de Asturias (1)  ·  James J. Peters Veterans Affairs Medical Center (1)  ·  Liaocheng People's Hospital (1)  ·  Molnlycke Health Care AB (1)  ·  Nitric BioTherapeutics, Inc (1)  ·  Pfizer (1)  ·  Phoenix Eagle Company (1)  ·  Precisio Biotix Therapeutics, Inc. (1)  ·  RegeneRx Biopharmaceuticals, Inc. (1)

Countries

United States (11)  ·  Australia (2)  ·  Canada (2)  ·  Taiwan (2)  ·  China (1)  ·  France (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Herbert B Slade, MD (2)  ·  Alexandre Moreau-Gaudry, Ph.D. M.D. (1)  ·  Barbara M Bates-Jensen, PhD (1)  ·  Chester H. Ho, MD (1)  ·  Chiu-Shong Liu, M.D. (1)  ·  Cristina Quesada, Nurse (1)  ·  Gina Suh, M.D. (1)  ·  Graciette Matioli, Doctor (1)  ·  Hector Bolivar, M.D. (1)  ·  Joel A. Aronowitz, M.D. (1)  ·  Karin Zachow, M.D. (1)  ·  Ken Hung, Ph.D. (1)  ·  Michael Longaker, MD (1)  ·  Michael Woodward, FRACP (1)  ·  Myroslav Romach, MSC, MD (1)

Results publications

PMID 21949432, PMID 24028358, PMID 31600109, PMID 33607926, PMID 34398099, PMID 35547633, PMID 37711926, PMID 37924749

NIH funding

R01AR045506 (1), R01NR020487 (1)